Clinical trialPhase 3
Lp(a)HORIZON (pelacarsen)
NCT04023552
Randomized double-blind placebo-controlled, 8 323 участника с CVD и Lp(a) ≥70 mg/dL.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT04023552
Original sources
Details
- Phase
- Phase 3
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.